US Merger & Acquisition SEC Filings — October 15, 2026

15-10-2026

Everest Consolidator Acquisition Corporation, a Delaware special purpose acquisition company (SPAC), filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation, signed October 14, 2026, that extends its Termination Date for completing an initial Business Combination to December 31, 2027. The amendment was approved by stockholders under Section 242 of the DGCL and specifies that if no business combination is completed by the Termination Date, the company will cease operations, redeem 100% of Offering Shares at a per-share trust-based price, and dissolve. The filing is principally a governance and timeline amendment, and the exhibit itself does not disclose a completed or signed acquisition target.

• · Original Certificate of Incorporation filed March 8, 2021; Amended and Restated Certificate filed November 23, 2021
• · Amendment adopted under Section 242 of the Delaware General Corporation Law by stockholders holding the requisite shares
• · Redemption price per share is the Trust Account balance (including interest, net of taxes and up to $100,000 for dissolution) divided by outstanding Offering Shares
• · Dissolution after redemption is subject to remaining stockholder and Board approval and creditor claim obligations under the DGCL

15-10-2026

Oaktree Acquisition Corp. III Life Sciences disclosed preliminary redemption results ahead of its October 16, 2026 extraordinary general meeting to extend its deadline for completing an initial business combination. Public shareholders tendered 13,326,977 Class A ordinary shares for redemption before the October 14, 2026 deadline, leaving an estimated 11,254,791 Class A and 1,000 Class B shares outstanding after the redemptions and conversion. The Sponsor will convert 4,798,758 Class B shares into Class A shares on a one-for-one basis, waiving trust account rights on those shares, so they remain non-redeemable founder shares with unchanged voting power.

• · Redemption deadline was 5:00 p.m. Eastern Time on October 14, 2026, and the extraordinary general meeting is scheduled for October 16, 2026
• · Shareholders may request withdrawal of redemptions by contacting Continental Stock Transfer & Trust Company
• · Sponsor waived trust account rights on converted shares under Article 166 of the Memorandum and Articles of Association
• · Converted shares remain subject to founder share restrictions, including transfer limits, redemption waiver, and voting obligation for a Business Combination
• · Class A and Class B shares vote together as a single class, so the conversion does not change the Sponsor's voting power

15-10-2026

Cronos Group Inc. (NASDAQ/TSX: CRON) completed its acquisition of CanAdelaar B.V., the largest operator in the Netherlands' Wietexperiment adult-use cannabis pilot, for a base purchase price of €57.5 million plus cash contingent consideration of 0.5x Normalized EBITDA in each of 2026 and 2027. The base price represents about 1.4x annualized net revenue and 2.9x annualized Adjusted EBITDA based on 1H 2026. However, CanAdelaar's performance is declining: annualized Adjusted EBITDA fell to €20.1 million for 1H 2026 from €24.2 million in the twelve months ended September 30, 2025, reflecting increased competition now that all licensed producers are operating.

• · CGM B.V. waived all contractual closing conditions via an addendum immediately before closing
• · Ring International Holding AG provided additional indemnities for certain regulatory and environmental matters, subject to contractual limitations
• · Base price is before closing and post-closing adjustments, including CanAdelaar's net debt position
• · Interim government report on the Wietexperiment (September 2026) described initial experiences as predominantly positive, though WODC noted effects are not yet firmly determinable
• · Wietexperiment is limited to ten municipalities excluding Amsterdam, covering about 1.7 million residents of 18.1 million in the Netherlands
• · Wietexperiment prohibits import, export, and inter-producer sales of cannabis

15-10-2026

byNordic Acquisition Corporation (BYNOW) funded its third one-month extension by depositing $8,850.20 into its trust account on October 9, 2026, moving the deadline to complete its initial business combination from October 12, 2026 to November 12, 2026. The extension is one of up to twelve permitted under the August 2026 charter amendment, which allows the board to extend up to August 12, 2027 without another stockholder vote. The filing contains no completed acquisition, target identification, or definitive agreement.

• · Stockholders approved the charter amendment at an August 6, 2026 annual meeting, allowing extension of the deadline to August 12, 2027, with the board able to elect monthly extensions without another vote.
• · The company's stated focus is high technology growth companies based in northern Europe, with no sector restriction on the target.
• · Common stock and warrants are quoted on the OTC Pink Limited Market (BYNO, BYNOW), not a national exchange.

15-10-2026

IB Acquisition Corp. (IBACR) set December 16, 2026 as the date of its first annual stockholder meeting since its IPO, with a record date of October 28, 2026, to regain compliance with Nasdaq Listing Rule 5620(a) after failing to hold an annual meeting within twelve months of fiscal year-end. The filing also sets a Rule 14a-8 stockholder proposal deadline of October 26, 2026. The disclosure is procedural and carries no reported financial results.

• · Annual Meeting to be held virtually via live webcast at 10:00 a.m. Eastern Time on Wednesday, December 16, 2026
• · Record date for stockholders entitled to notice of and to vote at the Annual Meeting is close of business on October 28, 2026
• · Rule 14a-8 stockholder proposals must be received by close of business on October 26, 2026 to be considered timely
• · Company received a Nasdaq Listing Qualifications letter on October 5, 2026 for non-compliance with Nasdaq Listing Rule 5620(a)
• · The Company is an emerging growth company and the Annual Meeting will be its first annual meeting since its IPO
• · Notice provided under Rule 14a-5(f) because no annual meeting was held in the prior year

15-10-2026

Melar Acquisition Corp. I (MACIU/MACI), a Cayman Islands SPAC, filed an 8-K furnishing an Everli Global Inc. press release (Exhibit 99.1) describing its asset-light Italian e-grocery marketplace, which partners with more than 95 retailers including all 13 of Italy's largest grocers, 1,150+ stores, and 300,000+ products across 60+ provinces. The filing reiterates the pending business combination under the July 30, 2025 Merger Agreement (as amended), with the combined company expected to trade on Nasdaq as Everli Global Holdings Inc. under the ticker EVRL. No financial results, deal valuation, or closing timing are disclosed in this filing.

• · Everli reports it is believed to be Italy's only gig delivery platform with a national union agreement
• · Everli operates with no warehouses, fleets, or added retailer staff, and offers a fully managed white-label service powering retailers' own branded online stores
• · Post-closing ticker for the combined company will be EVRL on Nasdaq
• · Registration Statement on Form S-4 has been declared effective, with the definitive proxy statement/prospectus mailed to Melar shareholders as of the September 28, 2026 record date
• · Filing is furnished as a Rule 425 communication, with cautionary forward-looking statement language covering risks including deal termination, shareholder approval, and Nasdaq listing maintenance

15-10-2026

Frazier Life Sciences Acquisition Corp. II, a special purpose acquisition company (SPAC), announced the pricing of its initial public offering of 7,500,000 Class A ordinary shares at $10.00 per share, for gross proceeds of $75 Million. The shares are expected to list on the Nasdaq Capital Market under ticker "FLSC" starting October 14, 2026, with closing expected October 15, 2026, subject to customary conditions. The company has no operating business and has not yet identified a target; it intends to pursue a biotechnology business combination, and the filing contains no reported operating financial results or prior-period comparisons.

• · Ticker symbol "FLSC" on the Nasdaq Capital Market, trading beginning October 14, 2026
• · Jefferies is sole book-running manager; registration statement declared effective by the SEC on October 13, 2026
• · Sponsor is Frazier Life Sciences Holdings II, LLC, an affiliate of Frazier Life Sciences Management, L.P.

15-10-2026

New America Acquisition I Corp. (NWAX-UN), a special purpose acquisition company, entered into an administrative services agreement dated October 15, 2026 with Dominari Holdings Inc., an affiliate of certain company officers and directors. Under the agreement, the company will pay $20,000 per month for office space and administrative services, starting October 15, 2026 and continuing until the earlier of its initial business combination or liquidation. Dominari also irrevocably waived any claims against the company's trust account holding IPO proceeds for public shareholders.

• · Dominari Holdings Inc. is an affiliate of certain company officers and directors, making this a related-party arrangement
• · Dominari irrevocably waived any claims against the trust account holding IPO proceeds, protecting public shareholder funds
• · Agreement governed by New York law and remains in effect until the company completes a business combination or liquidates

15-10-2026

Athena Technology Acquisition Corp. II (ATEK), a SPAC, notified its trustee on October 14, 2026 that it is extending the deadline to complete its initial business combination by one month, from October 14, 2026 to November 14, 2026, depositing $271.48 into the trust account. This is the fifth of up to nine monthly extensions permitted under its charter. The filing discloses no completed or proposed acquisition target.

• · Business combination deadline moved from October 14, 2026 to November 14, 2026
• · Up to four further monthly extensions remain available after this one

15-10-2026

Pine Tree Acquisition Corp. (PAXG), a Cayman Islands SPAC, consummated the sale of 600,000 units at $10.00 per unit on October 15, 2026, following a partial exercise of the over-allotment option granted to Maxim Group LLC, generating gross proceeds of $6,000,000. The Company also issued 24,000 Ordinary Shares to an entity designated by Maxim Group LLC, and reported that $106,000,000 of IPO and concurrent private placement net proceeds were deposited in the trust account for public shareholders.

• · Units trade on Nasdaq under PAXGU; Class A ordinary shares under PAXG; Rights under PAXGR
• · Each right entitles the holder to 3/4 of one Class A ordinary share upon completion of the initial business combination
• · Filing is an Item 8.01 (Other Events) disclosure accompanied by Exhibit 99.1 press release

15-10-2026

SPACSphere Acquisition Corp. (SSAC) entered into Amendment No. 1 to its Business Combination Agreement with Mobilewalla Holdco, Inc. on October 15, 2026, increasing the combined company board from five to seven directors effective at closing. The amendment adds two Mobilewalla-designated directors (Anindya Datta and Boris M. Gutin), one SPACSphere-designated director (Bala Padmakumar), and four independent directors, with the fourth independent director to be appointed before the Form S-4 is declared effective. The original Business Combination Agreement, dated May 29, 2026, otherwise remains in full force, and the transaction remains subject to shareholder approval, SEC effectiveness, and other closing conditions.

• · The SPAC will be de-registered in the Cayman Islands and continue into Delaware (Domestication), and will be renamed Covariate, Inc. upon closing.
• · The Business Combination Agreement was originally entered into May 29, 2026 and previously reported in an 8-K filed June 1, 2026.
• · The fourth independent director has not yet been named and will be appointed before the Form S-4 becomes effective.
• · Parties agreed to use reasonable best efforts to nominate and elect the designated directors effective at closing, subject to legal and Nasdaq limitations.
• · The 8-K was filed under Rule 425, indicating written communications related to a business combination.

15-10-2026

Pyrophyte Acquisition Corp. II (NYSE: PAII), a special purpose acquisition company, has entered into a definitive Business Combination Agreement with Sakuu Corporation, a San Jose-based developer of dry-printing electrode manufacturing platforms for batteries and supercapacitors. The transaction implies a pre-money equity value of $600 million for Sakuu, and upon closing Pyrophyte will be renamed Sakuu Corporation and listed on the NYSE under the ticker "SAKU." The deal remains subject to shareholder approval, regulatory approvals, and customary closing conditions, and no financial results or realized performance metrics for the period are disclosed in this filing.

• · Proceeds are expected to fund continued development of the Kavian Platform, preparations for anticipated commercial availability in Q2 2027, and purchase-order fulfillment
• · Sakuu's management (Bagheri and Niestroj) will continue to lead the company post-closing
• · The Business Combination was unanimously approved by both companies' boards of directors
• · Efficiency and safety benefits (cost, footprint, emissions, thermal runaway mitigation) are company claims and are not independently verified in the filing
• · The filing contains no revenue, earnings, cash balance, or trust account figures; redemption levels and net proceeds are not quantified